20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Gainers
- Aditxt (NASDAQ:ADTX) stock increased by 80.8% to $0.29 during Friday's regular session. Aditxt's stock is trading at a volume of 154.8 million shares as of 13:30 EST. This is 7570.0% of its average full-day volume over the last 100 days. The company's market cap stands at $12.9 million.
- Clovis Oncology (NASDAQ:CLVS) stock increased by 34.7% to $2.92. Trading volume for this security as of 13:30 EST is 84.8 million, which is 703.3% of its average full-day volume over the last 100 days. The company's market cap stands at $420.5 million.
- MyMD Pharmaceuticals (NASDAQ:MYMD) stock moved upwards by 30.1% to $3.89. Trading volume for MyMD Pharmaceuticals's stock is 1.8 million as of 13:30 EST. This is 2758.0% of its average full-day volume over the last 100 days. The company's market cap stands at $148.0 million.
- Oramed Pharmaceuticals (NASDAQ:ORMP) stock increased by 29.94% to $7.38. As of 13:30 EST, this security is trading at a volume of 3.6 million shares, making up 434.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $284.6 million.
- Organovo Holdings (NASDAQ:ONVO) shares moved upwards by 26.24% to $3.03. As of 13:30 EST, this security is trading at a volume of 440.3K shares, making up 1674.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $26.3 million.
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) stock moved upwards by 22.22% to $1.1. Trading volume for this security as of 13:30 EST is 549.6K, which is 100.7% of its average full-day volume over the last 100 days. The company's market cap stands at $53.5 million.
Losers
- Sight Sciences (NASDAQ:SGHT) shares fell 14.3% to $9.78 during Friday's regular session. Trading volume for this security as of 13:30 EST is 277.2K, which is 80.6% of its average full-day volume over the last 100 days. The company's market cap stands at $465.4 million.
- Gracell Biotechnologies (NASDAQ:GRCL) shares fell 12.25% to $4.26. As of 13:30 EST, this security is trading at a volume of 147.0K shares, making up 104.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $288.3 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) stock decreased by 12.16% to $0.31. AcelRx Pharmaceuticals's stock is trading at a volume of 5.2 million shares as of 13:30 EST. This is 273.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.6 million.
- iSpecimen (NASDAQ:ISPC) stock fell 10.82% to $2.64. The current volume of 203.0K shares is 91.0% of iSpecimen's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $23.2 million.
- Erytech Pharma (NASDAQ:ERYP) shares fell 10.73% to $1.04. The company's market cap stands at $32.2 million.
- ContraFect (NASDAQ:CFRX) shares fell 10.12% to $3.15. Trading volume for this security as of 13:30 EST is 141.5K, which is 106.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $124.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!